The use of bisphosphonates in children: review of the literature and guidelines for dental management

被引:36
作者
Bhatt, R. N. [1 ]
Hibbert, S. A. [1 ,2 ]
Munns, C. F. [3 ,4 ]
机构
[1] Westmead Ctr Oral Hlth, Dept Orthodont & Paediat Dent, Westmead, NSW 2145, Australia
[2] Childrens Hosp Westmead, Dept Dent, Westmead, NSW, Australia
[3] Childrens Hosp Westmead, Dept Endocrinol & Diabet, Westmead, NSW, Australia
[4] Univ Sydney, Sydney Med Sch, Discipline Paediat & Child Hlth, Sydney, NSW 2006, Australia
关键词
Bisphosphonate; BRONJ; child; dental; guideline; OSTEOGENESIS IMPERFECTA; INTRAVENOUS PAMIDRONATE; ZOLEDRONIC ACID; TOOTH ERUPTION; SEVERE HYPERCALCEMIA; OSTEONECROSIS; THERAPY; JAW; ADOLESCENTS; CHILDHOOD;
D O I
10.1111/adj.12140
中图分类号
R78 [口腔科学];
学科分类号
100302 [口腔临床医学];
摘要
Bisphosphonates are inhibitors of osteoclastic bone resorption with therapeutic benefit in a variety of bone disorders in both adults and children. While these agents have been routinely used in adults for the past three decades, their more recent introduction into paediatric medicine means there is a paucity of data on long-term safety and effects on dental development. There is uncertainty regarding the dental management of children treated with bisphosphonates, particularly when invasive dental procedures, such as extractions and oral surgical procedures, are required. There are limited data with which to make recommendations about the dental management of patients treated with bisphosphonates, and there are no published recommendations that specifically address paediatric patients. This paper aims to outline paediatric uses and adverse effects of bisphosphonates and present recommendations on the dental management of children receiving bisphosphonates.
引用
收藏
页码:9 / 19
页数:11
相关论文
共 72 条
[1]
Pamidronate:: Treatment for severe hypercalcemia in neonatal subcutaneous fat necrosis [J].
Alos, N ;
Eugène, D ;
Fillion, M ;
Powell, J ;
Kokta, V ;
Chabot, G .
HORMONE RESEARCH, 2006, 65 (06) :289-294
[2]
[Anonymous], 2012, THER GUID OR DENT VE
[3]
Clinical Review: Bisphosphonate Use in Childhood Osteoporosis [J].
Bachrach, Laura K. ;
Ward, Leanne M. .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2009, 94 (02) :400-409
[4]
Bagan Jose, 2007, Med Oral Patol Oral Cir Bucal, V12, pE336
[5]
Use of bisphosphonate therapy for osteoporosis in childhood and adolescence [J].
Batch, JA ;
Couper, JJ ;
Rodda, C ;
Cowell, CT ;
Zacharin, M .
JOURNAL OF PAEDIATRICS AND CHILD HEALTH, 2003, 39 (02) :88-92
[6]
Bhatt RN, 2010, BASELINE SURVEY ORAL
[7]
Preliminary experience with the combined use of recombinant bone morphogenetic protein and bisphosphonates in the treatment of congenital pseudarthrosis of the tibia [J].
Birke, Oliver ;
Schindeler, Aaron ;
Ramachandran, Manoj ;
Cowell, Chris T. ;
Munns, Craig F. ;
Bellemore, Michael ;
Little, David G. .
JOURNAL OF CHILDRENS ORTHOPAEDICS, 2010, 4 (06) :507-517
[8]
A review of the clinical implications of bisphosphonates in dentistry [J].
Borromeo, G. L. ;
Tsao, C. E. ;
Darby, I. B. ;
Ebeling, P. R. .
AUSTRALIAN DENTAL JOURNAL, 2011, 56 (01) :2-9
[9]
Effects of alendronate on tooth eruption and molar root formation in young growing rats [J].
Bradaschia-Correa, Vivian ;
Massa, Luciana F. ;
Arana-Chavez, Victor E. .
CELL AND TISSUE RESEARCH, 2007, 330 (03) :475-485
[10]
[British Dental Association Association BD], 2008, BISPH FACT FIL